Society for Endocrinology - a world-leading authority on hormones

News

Diabetes treatment also reduces heart failure risk

02 Sep 2019



Type 2 diabetes treatment, dapagliflozin, is also effective for reducing the risk of heart failure, according to research presented at the European Society of Cardiology conference in Paris.

Times